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Sirs: Among human neoplasms,
thymomas are associated with
highest frequency with paraneo-
plastic autoimmune diseases.
Myasthenia gravis (MG) is present
in 30 to 60 % [1], depending on the
subtype of thymoma. Paraneoplas-
tic pemphigus (PPP) on the other
hand is only rarely associated with
thymomas. The coincidence of MG
and PPP is very rare. Both, MG [2]
and PPP [3], are associated with
the occurrence of various autoanti-
bodies. Around 80 % of myasthenia
patients test positively for acetyl-
choline receptor antibodies [4]
while in PPP desmoglein-3 anti-
body titers are characteristically
elevated [5]. We here studied the
course of autoantibody titers be-
fore and after thymectomy in a pa-
tient with thymoma, MG and PPP.
Antibodies against acetylcholine
receptors (AChR) and against
desmoglein-1 and –3 showed a sig-
nificant decrease after thymectomy
in parallel to clinical improvement.
We report the case of a 53-year-
old woman who was admitted to
our hospital with fluctuating
diplopia, ptosis on her right side
and progressive fatigue for several
weeks. She reported progressive
dysphagia and weight loss of 15 kg
within a 6 month period. Further-
more, aphtous oral lesions
appeared five months prior to
admission. Neurological examina-
tion revealed slight weakness of the
cervical musculature, inconsistent
diplopia and ptosis on the right
side. Clinical myasthenic symp-
toms and elevated anti-acetyl-
choline receptor antibodies (3.3
pmol/ml; norm < 0.2 pmol/ml) led
to the diagnosis of myasthenia
gravis with predominant involve-
ment of oropharyngeal and ocular
muscles. CT scans of the chest re-
vealed a homogeneous 1.7 x 5.0 x
8.5 cm anterior mediastinal mass
consistent with a thymic tumor. CT
scans of the abdomen and the
pelvis were normal. Multiple geni-
tal, oral and pharyngeal bullous
and ulcerating eruptions were ob-
served, partly covered with white
creamy candida spots (Fig. 1A, in-
let). Histological findings included
interface dermatitis, apoptotic
keratinocytes and focal areas of
suprabasal acantholysis and were
consistent with the diagnosis of
paraneoplastic pemphigus
(Fig. 1A). In line with the clinical
and histological findings,
desmoglein-1 (anti-Dsg-1) anti-
bodies were initially normal (2.7
U/l; norm < 14 U/l), while the
desmoglein-3 (anti-Dsg-3) titer
(13.69 U/l; norm < 7 U/l) reached
twice the norm at admission
(Fig. 2).
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Fig. 1 A Paraneoplastic pemphigus with genital and oral blistering lesions (left inlet). Histology of genital blis-
tering lesions shows suprabasal acantholysis (bold arrows) and lichenoid tissue reaction (small arrow, magnifi-
cation 10x). Apoptotic keratinocytes are present (right inlet, arrowheads, 40x magnification). B Infiltration of the
mediastinal fat by the thymoma indicates stage III according to Masaoka (magnification 10x). Inlet demonstrat-
ing large polygonal epithelial cells with few lymphocytes in an area of thymoma type B3 (magnification 40x)
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Treatment with pyridostigmine
bromide, corticosteroids and aza-
thioprine lead to an improvement
of the myasthenic symptoms. After
significant recovery from myas-
thenic symptoms, the patient un-
derwent an elective transsternal
thymectomy seven weeks after her
first admission. Intraoperative
findings showed an infiltration of
mediastinal fat by the thymoma
(Stage Masaoka III) and simultane-
ous resection of pericardium and
the vena anonyma became neces-
sary. Histology showed a combined
thymoma of B2 and B3 type ac-
cording to the WHO classification
(Fig. 1B). The anterior medi-
astinum was postoperatively irra-
diated with a cumulative dose of
54 Gy.
Postoperatively, anti-Dsg-1 and
–3 antibodies showed a transient
increase. In contrast, AChR anti-
bodies dropped to almost normal
levels already seven weeks post-
operation and the patient showed
normal muscle strength under
continued pyridostigmine and
immunosuppressive therapy. Four
months after thymectomy,
desmoglein antibodies also showed
a significant decrease associated
with a slow resolution of the
mucous lesions.
Myasthenia gravis and pemphi-
gus are both part of an interesting
group of autoimmune diseases in
which the passive transfer of anti-
bodies can reproduce the disease
manifestation [3, 6]. While MG is
frequently associated with thy-
moma, PPP has only rarely been
reported in thymoma patients
[7–11]. We now report on a patient
with the rare triade of thymoma,
MG and PPP and describe for the
first time the course of desmoglein
antibodies before and after
thymectomy. In parallel with the
clinical recovery four months after
thymectomy, all, AChR and anti-
Dsg-1 and –3 antibodies showed an
impressive decline (Fig. 2). The
present case thus points out the
parallel dynamics of two autoim-
mune mechanisms with a possible
common denominator. In our case,
the levels of pemphigus-associated
antibodies had increased seven
weeks after thymectomy while
AChR antibodies already signifi-
cantly dropped. In parallel, clinical
stabilization of myasthenic symp-
toms preceded the resolution of the
mucous lesions. Furthermore, epi-
tope spreading leading to transi-
tion from an initial, mucosal domi-
nant type with only anti-Dsg3
antibodies, to an anti-Dsg1 (27.3
U/l) and anti-Dsg-3 (35.6 U/l) posi-
tive form had occurred. A similar
beneficial effect of tumor ablation
has recently also been reported in
the case of Castleman’s tumor, a
rare lymphoproliferative disease
that is sometimes associated with
paraneoplastic pemphigus [12].
Our data provide further evidence
for the important role of auto-
antibodies in the pathogenesis of
myasthenia gravis and paraneo-
plastic skin diseases in thymoma
patients and document the im-
provement of the associated dis-
eases after radical treatment of the
thymoma with concomitant im-
munosuppressive treatment.
Further studies are necessary to
analyze the pathomechanism
underlying the different time
course of the serological and clini-
cal resolution of MG and PMP after
thymectomy as presented in our
case.
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